Eli Lilly & Co $63.68

up +0.12


2/9/2014 04:00 PM  |  NYSE : LLY  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get LLY Trend Analysis - it has outperformed the S&P 500 by 1%

Partner Headlines

  1. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus
  2. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga
  3. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  4. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga
  5. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now Available ...

    Benzinga
  6. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  7. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  8. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga
  9. Thursday Morning Earnings Reports

    Benzinga
  10. Earnings Scheduled For July 24, 2014

    Benzinga
  11. New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis ...

    Benzinga
  12. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover And Co-Develop ...

    Benzinga
  13. Benzinga's Top #PreMarket Gainers

    Benzinga
  14. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  15. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  16. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  17. Benzinga's Top Upgrades

    Benzinga
  18. Eli Lilly is on the Right Track

    GuruFocus
  19. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  20. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  21. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  22. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  23. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  24. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  25. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent Activity

    Benzinga
  26. Eli Lilly insulin trial succeeds

    IBD
  27. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  28. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  29. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  30. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared to Insulin ...

    Benzinga
  31. Can Pfizer Make Up Its Loss?

    GuruFocus
  32. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  33. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  34. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  35. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  36. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  37. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  38. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  39. Actavis Earns Over-The-Top Q1

    IBD
  40. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  41. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  42. China Rule Change Further Opens Yuan To World Markets

    IBD
  43. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  44. Drugmakers' Q1 was anemic

    IBD
  45. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  46. Earnings Scheduled For April 24, 2014

    Benzinga
  47. Big Pharmas Swap Specialties

    IBD
  48. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  49. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  50. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
Trading Center